Beacon Pointe Advisors, LLC Amgen Inc Transaction History

Beacon Pointe Advisors, LLC

$8.35 Billion
Q2 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 119,678 shares of AMGN stock, worth $38.6 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

119,678

Previous 112,338 6.53%

Holding current value

$38.6 Million

Previous $31.9 Million 17.08%

% of portfolio

0.45%

Previous 0.36%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $1.93 Million - $2.34 Million	7,340 Added 6.53%	119,678 $37.4 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $1.1 Million - $1.32 Million	-4,075 Reduced 3.5%	112,338 $31.9 Million
Q4 2023 Feb 08, 2024	BUY	$255.7 - $288.46 $335,478 - $378,459	1,312 Added 1.14%	116,413 $33.5 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.71 Million - $5.85 Million	21,535 Added 23.02%	115,101 $30.9 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $3.5 Million - $4.14 Million	-16,335 Reduced 14.86%	93,566 $20.8 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $945,382 - $1.15 Million	-4,187 Reduced 3.67%	109,901 $26.6 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $1.63 Million - $2.07 Million	7,099 Added 6.64%	114,088 $30 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $4,938 - $5,569	22 Added 0.02%	106,989 $24.1 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $4.55 Million - $5.07 Million	-19,740 Reduced 15.58%	106,967 $26 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $9.93 Million - $11 Million	45,284 Added 55.62%	126,707 $30.6 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $3.57 Million - $4.08 Million	-17,943 Reduced 18.06%	81,423 $18.3 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $11.1 Million - $13 Million	52,392 Added 111.53%	99,366 $21.1 Million
Q2 2021 Aug 17, 2021	BUY	$233.58 - $259.14 $7.69 Million - $8.53 Million	32,906 Added 233.91%	46,974 $11.5 Million
Q1 2021 May 18, 2021	SELL	$221.91 - $258.6 $263,629 - $307,216	-1,188 Reduced 7.79%	14,068 $3.5 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $1.28 Million - $1.53 Million	5,925 Added 63.5%	15,256 $3.51 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $692,217 - $769,802	-2,950 Reduced 24.02%	9,331 $2.37 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $1.35 Million - $1.65 Million	6,800 Added 124.06%	12,281 $2.9 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $243,290 - $322,669	1,335 Added 32.2%	5,481 $1.11 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $784,464 - $1.01 Million	4,146 New	4,146 $1 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $673,109 - $806,524	-3,866 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $4,334 - $5,080	26 Added 0.68%	3,866 $713,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $5,606 - $6,320	-31 Reduced 0.8%	3,840 $730,000
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $690,586 - $806,135	3,871 New	3,871 $754,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Amgen Inc Transaction History